These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 12583546

  • 1. In-vitro activities of terbinafine, itraconazole and amphotericin B against Aspergillus and Cladosporium species.
    Kantarcioğlu AS, Yucel A.
    J Chemother; 2002 Dec; 14(6):562-7. PubMed ID: 12583546
    [Abstract] [Full Text] [Related]

  • 2. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
    Espinel-Ingroff A.
    J Clin Microbiol; 2001 Mar; 39(3):954-8. PubMed ID: 11230410
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In vitro activities of amphotericin B, terbinafine, and azole drugs against clinical and environmental isolates of Aspergillus terreus sensu stricto.
    Fernández MS, Rojas FD, Cattana ME, Sosa Mde L, Iovannitti CA, Lass-Flörl C, Giusiano GE.
    Antimicrob Agents Chemother; 2015 Mar; 59(6):3619-22. PubMed ID: 25824228
    [Abstract] [Full Text] [Related]

  • 5. Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species.
    Ryder NS, Leitner I.
    Med Mycol; 2001 Feb; 39(1):91-5. PubMed ID: 11270414
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp.
    Martín-Mazuelos E, Pemán J, Valverde A, Chaves M, Serrano MC, Cantón E.
    J Antimicrob Chemother; 2003 Sep; 52(3):365-70. PubMed ID: 12917236
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi.
    Espinel-Ingroff A.
    J Clin Microbiol; 2001 Apr; 39(4):1360-7. PubMed ID: 11283057
    [Abstract] [Full Text] [Related]

  • 8. In vitro activities of terbinafine against Aspergillus species in comparison with those of itraconazole and amphotericin B.
    Moore CB, Walls CM, Denning DW.
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1882-5. PubMed ID: 11353643
    [Abstract] [Full Text] [Related]

  • 9. Antifungal activity of amphotericin B and itraconazole against filamentous fungi: comparison of the Sensititre Yeast One and NCCLS M38--a reference methods.
    Carrillo-Muñoz AJ, Quindós G, Del Valle O, Hernández-Molina JM, Santos P.
    J Chemother; 2004 Oct; 16(5):468-73. PubMed ID: 15565914
    [Abstract] [Full Text] [Related]

  • 10. In vitro activity of terbinafine against medically important non-dermatophyte species of filamentous fungi.
    Garcia-Effron G, Gomez-Lopez A, Mellado E, Monzon A, Rodriguez-Tudela JL, Cuenca-Estrella M.
    J Antimicrob Chemother; 2004 Jun; 53(6):1086-9. PubMed ID: 15102749
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of terbinafine and itraconazole against Aspergillus species isolated from otomycosis.
    Karaarslan A, Arikan S, Ozcan M, Ozcan KM.
    Mycoses; 2004 Aug; 47(7):284-7. PubMed ID: 15310330
    [Abstract] [Full Text] [Related]

  • 12. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
    Kaya AD, Kiraz N.
    Mycoses; 2007 Nov; 50(6):447-50. PubMed ID: 17944704
    [Abstract] [Full Text] [Related]

  • 13. Effect of pH on the in vitro activities of amphotericin B, itraconazole, and flucytosine against Aspergillus isolates.
    Te Dorsthorst DT, Mouton JW, van den Beukel CJ, van der Lee HA, Meis JF, Verweij PE.
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3147-50. PubMed ID: 15273136
    [Abstract] [Full Text] [Related]

  • 14. Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus.
    Arikan S, Sancak B, Alp S, Hascelik G, McNicholas P.
    Med Mycol; 2008 Sep; 46(6):567-73. PubMed ID: 19180726
    [Abstract] [Full Text] [Related]

  • 15. Comparison of Sensititre YeastOne with the NCCLS M38-A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.
    Guinea J, Peláez T, Alcalá L, Bouza E.
    Diagn Microbiol Infect Dis; 2006 Sep; 56(1):53-5. PubMed ID: 16650953
    [Abstract] [Full Text] [Related]

  • 16. In vitro interaction of terbinafine with itraconazole and amphotericin B against fungi causing chromoblastomycosis in China.
    Yu J, Li R, Zhang M, Liu L, Wan Z.
    Med Mycol; 2008 Nov; 46(7):745-7. PubMed ID: 18608889
    [Abstract] [Full Text] [Related]

  • 17. In vitro evaluation of combination of terbinafine with itraconazole or amphotericin B against Zygomycota.
    Gómez-López A, Cuenca-Estrella M, Mellado E, Rodríguez-Tudela JL.
    Diagn Microbiol Infect Dis; 2003 Mar; 45(3):199-202. PubMed ID: 12663161
    [Abstract] [Full Text] [Related]

  • 18. MIC and fungicidal activity of terbinafine against clinical isolates of Aspergillus spp.
    Schmitt HJ, Bernard EM, Andrade J, Edwards F, Schmitt B, Armstrong D.
    Antimicrob Agents Chemother; 1988 May; 32(5):780-1. PubMed ID: 3134851
    [Abstract] [Full Text] [Related]

  • 19. In vitro susceptibility of respiratory isolates of Aspergillus species to itraconazole and amphotericin B. acquired resistance to itraconazole.
    Chryssanthou E.
    Scand J Infect Dis; 1997 May; 29(5):509-12. PubMed ID: 9435042
    [Abstract] [Full Text] [Related]

  • 20. In-vitro activity of voriconazole against Aspergillus spp. and comparison with itraconazole and amphotericin B.
    Oakley KL, Moore CB, Denning DW.
    J Antimicrob Chemother; 1998 Jul; 42(1):91-4. PubMed ID: 9700534
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.